Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Kenneth Duda, President and CTO of Arista Networks, completed a substantial sale of nearly 30,000 shares and exercised stock options, amidst the company's rising share price and ongoing favorable analyst recommendations. Additional share sales by trusts linked to Duda highlight internal liquidity actions as the company prepares for its upcoming ear…
Elliot Dean Hoops, serving as General Counsel and Secretary for MP Materials Corp, finalized a stock sale valued at approximately $533,606, disposing of 7,823 shares at varied prices in late January 2026. This transaction adhered to a previously established Rule 10b5-1 trading schedule. Concurrently, MP Materials has reported important progress in …
Christopher Gibson, director at Recursion Pharmaceuticals, sold 40,000 shares of Class A Common Stock in January 2026, coinciding with a stock conversion of Class B to Class A shares. Meanwhile, the company disclosed promising interim results from its Phase 1b/2 TUPELO trial assessing the investigational drug REC-4881, showing substantial reduction…
Jonathan Zalevsky, Chief Research and Development Officer at biopharmaceutical company Nektar Therapeutics, sold 3,867 company shares worth approximately $137,935 at an average price of $35.67 on January 20, 2026. This transaction follows recent mixed results from Nektar's Phase 2b REZOLVE-AA trial for alopecia areata, which narrowly missed its pri…
Campbell Bradley L., the President and CEO of Amicus Therapeutics, completed a sale of 75,000 shares on January 20, 2026, generating approximately $1.07 million. Alongside this, he exercised options to acquire an equal number of shares. This insider activity coincides with a strong market performance for Amicus shares and the announcement of an all…
EverCommerce Inc. CEO Eric Richard Remer completed two stock sale transactions in late January 2026, liquidating approximately $171,000 in shares through a structured trading plan. The company recently announced third-quarter 2025 results reflecting slight revenue gains yet received cautious analyst reactions, highlighting a balanced risk landscape…
Jay L. Schottenstein, serving as Executive Chairman and CEO of American Eagle Outfitters (NASDAQ:AEO), executed a series of stock sales totaling nearly $26.8 million by divesting 1,049,679 shares within a three-day period. Concurrently, the company has adjusted its fourth-quarter operating income forecast upward and announced a strategic global par…
In response to increasing global geopolitical tensions and soaring government debt, Bitwise and Proficio Capital Partners have introduced a novel exchange-traded fund (ETF) designed to offer investors diversified exposure to assets beyond traditional currencies. This ETF emphasizes precious metals such as gold, silver, platinum, and palladium along…
President Donald Trump voiced skepticism about a proposal from his chief economic adviser to permit individuals to withdraw money from their 401(k) retirement accounts to finance home down payments. Despite the administration's interest in expanding homeownership and making housing more affordable, Trump emphasized his preference for maintaining th…
John Alexander Kelly, CFO of Precision Biosciences Inc., sold over 15,000 shares at $4.03 each on January 21, 2026, amounting to just above $61,000. Concurrently, Kelly vested a substantial number of restricted stock units the previous day. Precision Biosciences continues to make progress in its gene editing programs and financial positioning amids…
Dario Scimeca, the General Counsel and Secretary of Precision BioSciences (NASDAQ:DTIL), executed the sale of 8,854 of the company’s common shares for a total of $35,681 on January 21, 2026. This transaction comes while the stock trades slightly above the sale price and amid an InvestingPro assessment rating the shares as overvalued. Concurrently, …
Precision Biosciences Inc's Chief Research Officer, Smith J. Jefferson, recently sold over 10,000 shares of the company's stock while concurrently acquiring a larger number of shares from vested Restricted Stock Units. The company continues to move forward with key gene editing clinical trials and maintains strong liquidity after a recent capital r…
U.S. stock futures held steady Thursday evening, stabilizing after a brief surge fueled by improving geopolitics around Greenland and enthusiasm for technology stocks, particularly those tied to artificial intelligence. Intel shares declined sharply after the chipmaker issued a cautious outlook for the upcoming quarter, overshadowing its better-tha…
Japanese Prime Minister Sanae Takaichi's call for an early general election on February 8 aims to secure public support for her aggressive reflation strategy, impacting bond yields and stirring debate on fiscal and monetary policy. Various political parties present contrasting approaches on taxation, fiscal discipline, and monetary policy, reflecti…
Mara Holdings CEO Frederick G. Thiel sold over 27,000 shares on January 20, 2026, netting approximately $297,000. The transaction was part of a pre-established trading plan, set against the backdrop of fluctuating cryptocurrency markets and varied analyst outlooks. Despite recent declines in Mara's stock tied to Bitcoin price weakness, the company’…
Abraham Ceesay, CEO of clinical-stage biotech firm Rapport Therapeutics, sold just over 10,900 shares valued at approximately $285,000 in two transactions under a pre-established trading plan. These dealings occur as the company expedites Phase 3 trials for its epilepsy drug RAP-219, earning favorable analyst responses and raising price targets for…
DraftKings Inc.'s Chief Legal Officer, Dodge R Stanton, recently undertook significant stock transactions involving both the sale of shares and the exercise of stock options. These actions took place against a backdrop of notable share price volatility, analyst optimism about the company’s potential profitability, and a fluctuating online sports be…
In January, British consumer confidence modestly strengthened to a level not seen since August 2024, as individuals expressed more optimism regarding their personal financial situations. Nonetheless, unease about the UK's overall economy remains pronounced, according to a recent GfK survey. The mixed sentiment reflects a focus on controllable perso…
President Donald Trump attributed a visible bruise on his left hand to his regular consumption of high-dose aspirin. Speaking to reporters aboard Air Force One following his trip to Davos, he explained the bruising resulted from bumping a table at the World Economic Forum and his aspirin regimen, which he believes helps maintain his heart health. M…
On January 20, 2026, Meta Platforms COO Javier Olivan sold a substantial portion of his Class A shares, signaling notable insider activity. Concurrently, regulatory approvals and analyst assessments are influencing perspectives on major tech and media firms, including Meta and ByteDance, impacting digital advertising and AI innovation sectors.
Frank Slootman, a director at Snowflake Inc., recently sold 180,070 shares valued at approximately $41.35 million, with transactions occurring in January 2026. Concurrently, Slootman exercised stock options to acquire additional shares at a modest price. The company's market activities coincide with its announced acquisition of Observe to bolster A…
James Francis Kessler, CEO of Rb Global, executed a sale of 20,742 shares valuing over $2.3 million while also exercising stock options, against the backdrop of the company's better-than-expected third quarter and a favorable rating upgrade from National Bank Financial. The company has further announced a quarterly dividend, reflecting confidence i…
Japan's core inflation rate eased in December compared to the previous month yet stayed above the Bank of Japan's 2% goal, sustaining expectations of potential interest rate increases. Despite the slowdown caused mainly by base effects from last year's energy price surge, underlying inflation remains robust. The BOJ is expected to maintain its poli…
Jennifer L. Wong, Chief Operating Officer of Reddit, Inc., sold 31,939 shares of the company's Class A Common Stock totaling approximately $8.8 million. The sales, conducted under a Rule 10b5-1 trading plan, took place on January 20, 2026, with prices ranging from $219.13 to $228.47 per share despite a recent 6.21% stock dip. Analysts offer varying…
Thomas Dean Fountain, EVP of Global Services & Strategy at F5 Networks, divested 1,110 shares valued at approximately $291,630 under a pre-established trading plan. Concurrently, F5 is advancing product innovation with newly launched AI security solutions and shows favorable analyst sentiment amid upcoming earnings.
